The European CRT Survey: 1 year (9-15 months) follow-up results.
about
Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian RegistryCardiac device therapy in patients with left ventricular dysfunction and heart failure: 'real-world' data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital).Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy.Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experienceEAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors.Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD.Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study.Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-AnalysisNational Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator.A ventricular assist device as a bridge to recovery, decision making, or transplantation in patients with advanced cardiac failure.2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.Heart failure highlights in 2012-2013.Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.Cardiac resynchronization therapy: results, challenges and perspectives for the future.Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry.Co-Morbidities and Cardiac Resynchronization Therapy: When Should They Modify Patient Selection?Long-term performance of modern coronary sinus leads in cardiac resynchronization therapy.Complete atrioventricular block does reduce mortality in patients with atrial fibrillation treated with cardiac resynchronization therapy: reply.Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry.Improvement of cardiac function with device-based diaphragmatic stimulation in chronic heart failure patients: the randomized, open-label, crossover Epiphrenic II Pilot Trial.Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure.Regional variations in baseline characteristics of cardiac rhythm device recipients: The PANORAMA observational cohort study☆.Regional variations in baseline characteristics of cardiac rhythm device recipients: The PANORAMA observational cohort study.Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey.The year in cardiology 2017: arrhythmias and cardiac devices.Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID-CRT risk score.Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy.Clinical outcome after 1 year of cardiac resynchronisation therapy: national results from the European CRT survey.Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead
P2860
Q30594176-6F850804-3370-4240-943A-7D7428ABB836Q31072272-86725137-2D88-4807-BAE2-59E9D3F4DC08Q33880742-6EFE1044-510F-4EB0-855C-E49EA25E7AC7Q35023289-E6A9D365-1ED5-4B78-A17A-CD34ED1EA4CBQ35035181-E4891CD6-6AC7-43F1-989C-5C129E8035F2Q36339905-1F654A36-6DE6-46ED-BC57-BB994AC5D7D3Q36424877-FB4B4B7A-8347-450C-B176-DF24F006D61DQ36836290-955BB9FD-2F00-4B58-B570-FECD5559243CQ37602252-BC0AA16F-175B-42E5-BB6C-CFFCFAAADEB0Q38027734-F3228F01-B1A1-47F7-9E0D-3734E6DDE81DQ38038846-3670B50C-9923-44A4-8B3B-9D3F89D6D429Q38182010-C10835FF-21A9-48D7-AF63-B3EABA87FFA0Q38452103-07841317-863F-47BC-B4E7-44E020010AA9Q38826268-34D5F507-28F4-43E5-BE72-6A82BE1FF767Q38972837-A122F562-A412-4E1E-884C-07505BA37564Q39037093-9455AFE7-9A06-4031-B692-D3D7A90885DEQ39916578-C8AB5BD8-521F-4E81-8D4E-340E6F0F3DD1Q43743916-C4FE6870-F2DB-460E-BF76-4F1C024F3339Q43998937-3B861D79-ACC8-40D4-8493-CDC4D6F1073AQ45721660-9834AD5E-FCD7-4B0E-870E-7537FF169811Q47631882-376C2D92-5586-49FC-BDD3-5F33AC91B1A2Q49452368-A7CFDE25-91E9-460C-8A7C-DAF55D0E87BAQ49953857-9E168E2E-EA83-4F70-BD9C-B2AE1B7723F1Q50080851-75958EA6-9D5E-459C-8E22-D1AEAFE2D377Q50193711-B72E4654-E164-4951-A7A3-AE61DD344C1BQ53255168-059FEE2E-CA0B-4FAB-9E27-D774915100E1Q53539379-999DA6A0-93D3-44C0-8EBA-0829684F3BE3Q54563143-56B9219A-88CA-4272-B63D-0CB558CE29E3Q54716526-1CDFE302-4519-4CF9-A734-B41E96D68BDBQ56977333-5919C77F-FF94-47DC-867F-B4830F8B489E
P2860
The European CRT Survey: 1 year (9-15 months) follow-up results.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The European CRT Survey: 1 year (9-15 months) follow-up results.
@en
The European CRT Survey: 1 year
@nl
type
label
The European CRT Survey: 1 year (9-15 months) follow-up results.
@en
The European CRT Survey: 1 year
@nl
prefLabel
The European CRT Survey: 1 year (9-15 months) follow-up results.
@en
The European CRT Survey: 1 year
@nl
P2093
P2860
P50
P356
P1476
The European CRT Survey: 1 year (9-15 months) follow-up results.
@en
P2093
Anselm Gitt
Christoph Stellbrink
Daniel Gras
Fredrik Gadler
John G F Cleland
Laszlo Buga
Maurizio Gasparini
Scientific Committee, National Coordinators, and Investigators
Silvia Priori
Tobias Limbourg
P2860
P356
10.1093/EURJHF/HFR158
P50
P577
2012-01-01T00:00:00Z